The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
October 29, 2025 at 6:40 PM
The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
October 23, 2025 at 2:20 PM
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
October 22, 2025 at 7:15 PM
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
October 22, 2025 at 7:09 PM
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
October 22, 2025 at 6:03 PM
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
October 22, 2025 at 3:54 PM
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
October 22, 2025 at 1:00 PM
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
September 24, 2025 at 4:26 PM
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
September 10, 2025 at 4:23 PM
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
Submit an Abstract for the 2025 Young Investigator Symposium by Thursday, 9/11! 🩻
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
August 21, 2025 at 4:42 PM
Submit an Abstract for the 2025 Young Investigator Symposium by Thursday, 9/11! 🩻
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol ow.ly/K86r50BK0Gj #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm
August 20, 2025 at 7:51 PM
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol ow.ly/K86r50BK0Gj #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
July 28, 2025 at 9:07 PM
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
July 21, 2025 at 3:15 PM
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
July 14, 2025 at 1:35 AM
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Excited to have shared our work at @ASCO 2025!
We developed an explainable AI pathology model to predict docetaxel benefit in high-risk localized and mHSPC. Collab w/ @eaonc @RTOGFoundation @WinshipAtEmory. #ASCO2025
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
We developed an explainable AI pathology model to predict docetaxel benefit in high-risk localized and mHSPC. Collab w/ @eaonc @RTOGFoundation @WinshipAtEmory. #ASCO2025
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
June 15, 2025 at 2:47 AM
Excited to have shared our work at @ASCO 2025!
We developed an explainable AI pathology model to predict docetaxel benefit in high-risk localized and mHSPC. Collab w/ @eaonc @RTOGFoundation @WinshipAtEmory. #ASCO2025
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
We developed an explainable AI pathology model to predict docetaxel benefit in high-risk localized and mHSPC. Collab w/ @eaonc @RTOGFoundation @WinshipAtEmory. #ASCO2025
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
👏 Congrats to OUCH-I Chair & Founder Dr. Joan H. Schiller on winning the 2025 #EAOnc Remarkable Mentor in Oncology Award, a true leader in lung cancer research & mentorship! #LungCancer #Oncology #Mentorship #OUCH
May 25, 2025 at 6:35 PM
👏 Congrats to OUCH-I Chair & Founder Dr. Joan H. Schiller on winning the 2025 #EAOnc Remarkable Mentor in Oncology Award, a true leader in lung cancer research & mentorship! #LungCancer #Oncology #Mentorship #OUCH
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol ow.ly/K86r50BK0Gj #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm
May 18, 2025 at 10:57 PM
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol ow.ly/K86r50BK0Gj #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
May 18, 2025 at 10:57 PM
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie ow.ly/9Z2o30oEn9T
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd
#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD ow.ly/aVr250BZ0dw #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd
May 18, 2025 at 10:55 PM
#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD ow.ly/aVr250BZ0dw #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd
Powerful talk on building strong patient-oncologist relationships by #CancerResearch advocate and #KidneyCancer survivor Glenn Sykes during our Spring 2025 General Session. #EAOnc
May 14, 2025 at 10:43 PM
Powerful talk on building strong patient-oncologist relationships by #CancerResearch advocate and #KidneyCancer survivor Glenn Sykes during our Spring 2025 General Session. #EAOnc
Congratulations to the 2025 #EAOnc Remarkable Mentor in Oncology Award recipient, Dr. Joan Schiller of @lungcancerresearch.bsky.social @ouchinternational.bsky.social! #mentorship #LungCancer
May 14, 2025 at 10:35 PM
Congratulations to the 2025 #EAOnc Remarkable Mentor in Oncology Award recipient, Dr. Joan Schiller of @lungcancerresearch.bsky.social @ouchinternational.bsky.social! #mentorship #LungCancer
Congratulations to Dr. Zachary Avigan of the Icahn School of Medicine at Mount Sinai on receiving the 2025 #EAOnc Paul Carbone, MD Fellowship Award! #CancerResearch #ClinicalTrials #MultipleMyeloma
May 14, 2025 at 10:08 PM
Congratulations to Dr. Zachary Avigan of the Icahn School of Medicine at Mount Sinai on receiving the 2025 #EAOnc Paul Carbone, MD Fellowship Award! #CancerResearch #ClinicalTrials #MultipleMyeloma
Congratulations to @pgrivasmdphd.bsky.social of @uwmedicine.bsky.social @fredhutch.bsky.social on receiving the 2025 #EAOnc Young Investigator Award. Well deserved! #CancerResearch #ClinicalTrials #BladderCancer
May 14, 2025 at 9:57 PM
Congratulations to @pgrivasmdphd.bsky.social of @uwmedicine.bsky.social @fredhutch.bsky.social on receiving the 2025 #EAOnc Young Investigator Award. Well deserved! #CancerResearch #ClinicalTrials #BladderCancer
A #mmsm classic -> Vincent Rajkumar (@VincentRK): from Madras to Minnesota for myeloma - @TheLancet ow.ly/ElUQk @eaonc
Vincent Rajkumar: from Madras to Minnesota for myeloma
Challenging assumptions seems to be in the blood of Vincent Rajkumar. Take his taste
in music. Cerebral, temperate, and mild-mannered are the adjectives that spring immediately
to mind as he talks fon...
ow.ly
May 14, 2025 at 1:07 PM
A #mmsm classic -> Vincent Rajkumar (@VincentRK): from Madras to Minnesota for myeloma - @TheLancet ow.ly/ElUQk @eaonc